AptaC – Aptamers and fusion aptamers binding haemostatic molecules for diagnostic and therapeutic use

Activated protein C (APC) plays a key role in vascular and inflammatory diseases. As endogenous inhibitor APC inactivates blood clotting factors Va and VIIIa controlling plasmatic haemostasis.

The inventions provide aptamers as diagnostic tools for detection of APC in biological samples also in the presence of abundant inactive protein C with high selective specificity. This allows establishment of routine diagnostics for APC to analyse disturbances in haemostasis, e.g. in sepsis or in haemophilia A. Further the inventions provide therapeutic aptamers binding to APC for the control of bleeding events, e.g. in haemophilia A or Willebrand syndrome.

Further Information: PDF

PROvendis GmbH
Phone: +49 (0)208/94105 0

Dipl.-Ing. Alfred Schillert

Media Contact

info@technologieallianz.de TechnologieAllianz e.V.

Alle Nachrichten aus der Kategorie: Technology Offerings

Zurück zur Startseite

Kommentare (0)

Schreib Kommentar

Neueste Beiträge

Who stole the light?

Self-induced ultrafast demagnetization limits the amount of light diffracted from magnetic samples at soft x-ray energies. Free electron X-ray lasers deliver intense ultrashort pulses of x-rays, which can be used…

Could breadfruit be the next superfood?

UBC researchers say yes Breadfruit is sustainable, environmentally friendly and a high-production crop. A fruit used for centuries in countries around the world is getting the nutritional thumbs-up from a…

New calculation refines comparison of matter with antimatter

Theorists publish improved prediction for the tiny difference in kaon decays observed by experiments. -An international collaboration of theoretical physicists–including scientists from the U.S. Department of Energy’s (DOE) Brookhaven National…

By continuing to use the site, you agree to the use of cookies. more information

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.